This inventor holds 1 USPTO granted patent. Top assignee: Synvaccine Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Oriah Mioduser: Innovator in Viral Synthetic Nucleic Acid Sequences
Introduction
Oriah Mioduser is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of synthetic nucleic acids, particularly in the development of viral synthetic nucleic acid sequences. His work has implications for various applications in biotechnology and medicine.
Latest Patents
Oriah Mioduser holds a patent for "Viral synthetic nucleic acid sequences and use thereof." This patent includes nucleic acid molecules that comprise a coding sequence with at least one codon substituted to a synonymous codon. It also covers a modified form of a virus that incorporates these nucleic acid molecules, along with methods for producing these nucleic acid molecules and viruses. He has 1 patent to his name.
Career Highlights
Mioduser is associated with Synvaccine Ltd., where he applies his expertise in synthetic biology. His innovative approach to viral nucleic acids has positioned him as a key figure in the biotechnology sector.
Collaborations
He has collaborated with notable colleagues, including Tamir Tuller and Eli Goz, who share his passion for advancing research in synthetic nucleic acids.
Conclusion
Oriah Mioduser's work in viral synthetic nucleic acid sequences showcases his innovative spirit and dedication to advancing biotechnology. His contributions are paving the way for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile